Clinical impact of multidisciplinary carbapenem stewardship interventions: a retrospective cohort study

References

• World Health Organization. Antimicrobial resistance: global report on surveillance, Vol. 61, World Health Organization. Geneva: World Health Organization; 2014, pp. 383–94.
   Google Scholar
• Ministry of Health MalaysiaNational antibiotic guideline20193Kuala LumpurPharmaceutical Services Programme, Ministry of Health Malaysia
   Google Scholar
• Ministry of Health MalaysiaMalaysian action plan on antimicrobial resistance (MyAP-AMR) 2017–20212017Kuala LumpurMinistry of Health Malaysia
   Google Scholar
• Institute for Medical ResearchNational antibiotic resistance surveillance report2017Kuala LumpurMinistry of Health Malaysia
   Google Scholar
• World Health OrganizationGlobal action plan on antimicrobial resistance [Internet]2015GenevaWorld Health Organization
   Google Scholar
• Barlam TF, Cosgrove SE, Abbo LM, Macdougall C, Schuetz AN, Septimus EJ, et al.Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of AmericaClin Infect Dis20166210e5177 10.1093/cid/ciw118 27080992 5006285
   PubMed Web of Science ®Google Scholar
• Nathwani D, Varghese D, Stephens J, Ansari W, Martin S, Charbonneau CValue of hospital antimicrobial stewardship programs [ASPs]: a systematic reviewAntimicrob Resist Infect Control201981113 10.1186/s13756-019-0471-0
   PubMed Web of Science ®Google Scholar
• Lew KY, Ng TM, Tan M, Tan SH, Lew EL, Ling LM, et al.Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic settingJ Antimicrob Chemother201470412191225 10.1093/jac/dku479 25473028
   PubMed Web of Science ®Google Scholar
• Teng CB, Ng TM, Tan MW, Tan SH, Tay M, Lim SF, et al.Safety and effectiveness of improving carbapenem use via prospective review and feedback in a multidisciplinary antimicrobial stewardship programmeAnn Acad Med Singapore20154411925 10.47102/annals-acadmedsg.V44N1p19 25703493
   PubMed Web of Science ®Google Scholar
• Seah VXF, Ong RYL, Lim ASY, Chong CY, Tan NWH, Thoon KCImpact of a carbapenem antimicrobial stewardship program on patient outcomesAntimicrob Agents Chemother201761919 10.1128/AAC.00736-17
   Web of Science ®Google Scholar
• Palacios-Baena ZR, Delgado-Valverde M, Valiente Méndez A, Almirante B, Gómez-Zorrilla S, Borrell N, et al.Impact of de-escalation on prognosis of patients with bacteremia due to enterobacteriaceae: a post hoc analysis from a multicenter prospective cohortClin Infect Dis2018696956962 10.1093/cid/ciy1032
   Web of Science ®Google Scholar
• Gaur AH, English BKThe judicious use of antibiotics—an investment towards optimized health careIndian J Pediatr2006734343350 10.1007/BF02825829 16816496
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis1987405373383 1:STN:280:DyaL2s7ms1GnsQ%3D%3D 10.1016/0021-9681(87)90171-8 3558716
   PubMedGoogle Scholar
• Pharmaceutical Care Network Europe. The PCNE Classification for Drug Related Problems V8.01. 2017.
   Google Scholar
• Fleiss JLStatistical Methods for Rates and Proportions19811New YorkJohn Wiley & Sons
   Google Scholar
• Ramadas A, Lin Teh H, Ambaras Khan R, Lii Ching S, Hassan R, Loon Leong C, et al.Impact of an antibiotic stewardship program on the use of carbapenem in a malaysian tertiary hospital (ACTION)Malaysian J Pharm202281
   Google Scholar
• Loo LW, Liew YX, Lee W, Lee LW, Chlebicki P, Kwa ALHDiscontinuation of antibiotic therapy within 24 hours of treatment initiation for patients with no clinical evidence of bacterial infection: a 5-year safety and outcome study from Singapore General Hospital Antimicrobial Stewardship ProgramInt J Antimicrob Agents.2019535606611 1:CAS:528:DC%2BC1MXls1Ojurk%3D 10.1016/j.ijantimicag.2019.01.008 30639630
   PubMed Web of Science ®Google Scholar
• Sadyrbaeva-Dolgova S, Aznarte-Padial P, Pasquau-Liaño J, Expósito-Ruiz M, Calleja Hernández MÁ, Hidalgo-Tenorio CClinical outcomes of carbapenem de-escalation regardless of microbiological results: a propensity score analysisInt J Infect Dis2019858087 1:CAS:528:DC%2BC1MXhtVyns7jF 10.1016/j.ijid.2019.04.034 31075508
   PubMed Web of Science ®Google Scholar
• Yeo CL, Wu JE, Chung GW, Chan DS, Chen HH, Hsu LYAntimicrobial stewardship auditing of patients reviewed by infectious diseases physicians in a tertiary university hospitalAntimicrob Resist Infect Control20132115 10.1186/2047-2994-2-29
   PubMedGoogle Scholar
• Okumura LM, da Silva MMG, Veroneze IEffects of a bundled antimicrobial stewardship program on mortality: a cohort studyBraz J Infect Dis2015193246252 10.1016/j.bjid.2015.02.005 25892314 9425345
   PubMed Web of Science ®Google Scholar
• Rumbus Z, Matics R, Hegyi P, Zsiboras C, Szabo I, Illes A, et al.Fever is associated with reduced, hypothermia with increased mortality in septic patients: a meta-analysis of clinical trialsPLoS ONE2017121 10.1371/journal.pone.0170152 28081244 5230786
   PubMed Web of Science ®Google Scholar
• Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, et al.Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational studyCrit Care2012161R33 10.1186/cc11211 22373120 3396278
   PubMed Web of Science ®Google Scholar
• Niven DJ, Laupland KBPyrexia: aetiology in the ICUCrit Care2016201247 10.1186/s13054-016-1406-2 27581757 5007859
   PubMedGoogle Scholar